Hormone therapy has spent decades at the center of one of women’s health’s most confusing debates. Now two new studies are adding another provocative question: could menopausal hormone therapy also influence a woman’s later risk of dementia?
The findings are intriguing, especially because women account for a large majority of Alzheimer’s cases. But they do not prove that hormone therapy prevents dementia, and women should not start taking hormones solely to protect their brains based on these studies. What they do suggest is that the relationship between estrogen, menopause and brain aging may be more complicated than we once thought.
Why researchers are looking at estrogen and the brain
Estrogen affects much more than reproduction. The brain contains estrogen receptors, and estrogen is involved in blood flow, energy use, inflammation and communication between nerve cells. When estrogen levels decline during menopause, researchers have long wondered whether that transition influences later neurological health.
That doesn’t mean estrogen loss causes Alzheimer’s disease. Dementia develops through a complex combination of age, genetics, cardiovascular health and many other factors. Hormones may be one piece of a much larger puzzle.
One large study found a lower dementia risk among hormone users
A 2026 analysis using data from more than 183,000 postmenopausal women in the UK Biobank found that women who had used hormone replacement therapy for at least a year had about a 10% lower risk of developing dementia during follow-up.
The association appeared stronger in certain groups, including women who had experienced surgical menopause, women carrying the APOE e4 genetic variant and women with lower lifetime estrogen exposure. The study is summarized by the UK Biobank.
But there is a crucial word here: association. The researchers observed differences between women who did and didn’t use hormone therapy. They did not randomly assign women to take hormones and prove that the treatment prevented dementia.
Another study looked directly at Alzheimer’s changes in the brain
A separate study published in *Neurology* examined menopausal hormone therapy in relation to Alzheimer’s-related brain pathology. Researchers found an association between estrogen-only therapy and lower odds of certain Alzheimer’s neuropathological changes.
Again, this doesn’t establish cause and effect. Women who choose hormone therapy may differ from nonusers in healthcare access, education, socioeconomic status, underlying health and other ways that can influence dementia risk.
Two studies pointing in a similar direction make the question more interesting. They do not turn the answer into a certainty.
Why earlier research caused so much confusion
The hormone-and-dementia story has been complicated for decades partly because “hormone therapy” is not one single treatment. Formulations differ, estrogen may be used alone or with a progestogen, doses and delivery methods vary, and women begin treatment at very different ages.
Timing may be particularly important. Some researchers have proposed a “window of opportunity” around the menopause transition when hormone therapy may affect the brain differently than treatment first started many years later.
That helps explain why studies involving women who begin therapy near menopause may not produce the same results as studies of older women beginning hormones well after menopause.
Save this article
Enter your email address and we'll send it straight to your inbox.
Hormone therapy already has established uses
Menopausal hormone therapy remains the most effective treatment for bothersome hot flashes and night sweats and can help prevent bone loss. Local vaginal estrogen and other treatments can also address genitourinary symptoms of menopause.
Whether systemic hormone therapy is appropriate depends on a woman’s symptoms, age, time since menopause, medical history and individual risk factors.
Dementia prevention is not currently an established indication for menopausal hormone therapy. That’s an important distinction when headlines make new observational research sound like a treatment recommendation.
What women considering hormone therapy should actually ask
Instead of asking, “Should I take hormones so I don’t get Alzheimer’s?” a more useful conversation begins with why hormone therapy is being considered in the first place.
Are hot flashes disrupting sleep? Are night sweats affecting daily functioning? Is bone health a concern? What is your cardiovascular and breast-cancer history? How long has it been since menopause? What formulation and route make sense?
Brain health can certainly be part of that discussion, but the decision should be based on the total balance of known benefits, risks and the symptoms being treated—not one promising dementia study.
There are proven ways to support brain health now
While researchers continue studying hormones, women don’t have to wait for a dementia-prevention strategy. Managing blood pressure, cholesterol and diabetes; exercising regularly; avoiding smoking; treating hearing loss; sleeping adequately; maintaining social connection and staying physically and mentally active all contribute to healthier aging.
None guarantees that someone won’t develop dementia. But they address risk factors supported by a much broader body of evidence than using hormone therapy specifically for Alzheimer’s prevention.
Final word
The new research is important because women’s brains have historically received far less attention in menopause research than hot flashes, fertility and bones. Understanding how the dramatic hormonal transition of menopause might interact with brain aging is a question worth pursuing aggressively.
For now, though, “hormone therapy was associated with lower dementia risk” is not the same as “hormone therapy prevents dementia.” Women considering menopausal hormones should make that decision based on their own symptoms, health history and established evidence while researchers continue working out what the brain findings mean.
If hormone therapy were eventually shown to influence long-term brain health, would that change how you think about treating menopause symptoms today?
More articles:
